1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. ANIMAL PARASITICIDES MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Ectoparasiticides
5.3. Endoparasiticides
5.4. Endectocides
6. ANIMAL PARASITICIDES MARKET BY PARASITE TYPE
6.1. Introduction
6.2. Internal
6.3. External
6.3.1. Ticks
6.3.2. Fleas
6.3.3. Others
7. ANIMAL PARASITICIDES MARKET BY MODE OF ADMINISTRATION
7.1. Introduction
7.2. Oral
7.3. Injectable
8. ANIMAL PARASITICIDES MARKET BY ANIMAL TYPE
8.1. Introduction
8.2. Companion Animals
8.3. Livestock Animals
8.3.1. Cattle
8.3.2. Poultry
8.3.3. Swine
8.3.4. Others
9. ANIMAL PARASITICIDES MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. By Product Type
9.2.2. By Parasite Type
9.2.3. By Mode of Administration
9.2.4. By Animal Type
9.2.5. By Country
9.2.5.1. USA
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. South America
9.3.1. By Product Type
9.3.2. By Parasite Type
9.3.3. By Mode of Administration
9.3.4. By Animal Type
9.3.5. By Country
9.3.5.1. Brazil
9.3.5.2. Argentina
9.3.5.3. Others
9.4. Europe
9.4.1. By Product Type
9.4.2. By Parasite Type
9.4.3. By Mode of Administration
9.4.4. By Animal Type
9.4.5. By Country
9.4.5.1. Germany
9.4.5.2. France
9.4.5.3. United Kingdom
9.4.5.4. Spain
9.4.5.5. Others
9.5. Middle East and Africa
9.5.1. By Product Type
9.5.2. By Parasite Type
9.5.3. By Mode of Administration
9.5.4. By Animal Type
9.5.5. By Country
9.5.5.1. Saudi Arabia
9.5.5.2. UAE
9.5.5.3. Israel
9.5.5.4. Others
9.6. Asia Pacific
9.6.1. By Product Type
9.6.2. By Parasite Type
9.6.3. By Mode of Administration
9.6.4. By Animal Type
9.6.5. By Country
9.6.5.1. China
9.6.5.2. India
9.6.5.3. Japan
9.6.5.4. South Korea
9.6.5.5. Indonesia
9.6.5.6. Thailand
9.6.5.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Boehringer Ingelheim GmbH
11.2. Elanco
11.3. Virbac Corporation
11.4. Merck & Co., Inc.
11.5. Zoetis
11.6. Vetoquinol S.A.
11.7. Ceva Santé Animale
11.8. Perrigo Company Plc,
11.9. Norbrook Laboratories
11.10. Bimeda Inc.
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES